The FDA has approved the first digital pill that tracks if and when patients have taken their medication. The drug is Abilify MyCite, which can be used to treat schizophrenia and bipolar I disorder. The pill includes an embedded ingestible sensor that is the size of a grain of sand. After ingesting the sensor hits stomach fluids, it generates a timestamped ID signal and sends a message to a wearable patch that the medication was taken. The patch, which is meant to be worn on the left rib cage and must be replaced once a week, wirelessly sends the recorded date and time to the mobile app. The patient could see his info via the Discover app on their mobile phone or device.”]